A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
PHASE2
This is phase 2 single arm study evaluating the safety and preliminary effi...
Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer
PHASE1
This is an open-label, phase 1 clinical trial to evaluate the safety and pr...
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
PHASE2
This is a phase 2, three-cohort (2 randomized and 1 single-arm), open-label...
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
PHASE2
This phase II/III Lung-MAP trial studies how well immunotherapy treatment w...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham